As of 2025-06-21, the Relative Valuation of Cell MedX Corp (CMXC) is (2.48) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.45 USD, the upside of Cell MedX Corp based on Relative Valuation is -653.9%.
The range of the Relative Valuation is (1.99) - (2.87) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.3x - 28.8x | 24.1x |
| Forward P/E multiples | 19.3x - 27.9x | 24.1x |
| Fair Price | (1.99) - (2.87) | (2.48) |
| Upside | -543.1% - -741.7% | -653.9% |
| Date | P/E |